Dynamic MRI of breast hardness following radiation treatment

Journal of Magnetic Resonance Imaging

Volumn 17, Issue 4, 2003, Pages 427-434

  Padhani, Anwar R ^a,c   Yarnold, John ^b   Regan, Jane ^b   Husband, Janet E ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Magnetic resonance imaging; Normal tissues; Radiotherapy; Tissue perfusion

Indexed keywords

CONTRAST MEDIUM;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; BREAST CARCINOMA; BREAST EXAMINATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; EDEMA; FAT NECROSIS; FEMALE; HARDNESS; HUMAN; IMAGE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARENCHYMA; PRIORITY JOURNAL; TISSUE CHARACTERIZATION;

BREAST; BREAST NEOPLASMS; EDEMA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; RADIOTHERAPY; STATISTICS, NONPARAMETRIC;

EID: 12244295439     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.10257     Document Type: Article

References (41)

1. Rubin P, Casarett GW. Clinical radiation pathology, Volumes I and II. W.B. Saunders Company, Philadelphia; 1968. 1057 p.
2. Fajardo LF, Berthrong M. Radiation injury in surgical pathology. Part I. Am J Surg Pathol 1978;2:159-199.
3. Gowing NF. Pathological changes in the bladder following irradiation. Br J Radiol 1960;33:484-487.
4. Veinot JP, Edwards WD. Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases. Hum Pathol 1996;27:766-773.
5. Lewin K, Millis RR. Human radiation hepatitis. A morphologic study with emphasis on the late changes. Arch Pathol 1973:96:21-26.
6. Clarke D, Curtis JL, Martinez A, Fajardo L, Goffinet D. Fat necrosis of the breast simulating recurrent carcinoma after primary radiotherapy in the management of early stage breast carcinoma. Cancer 1983:52:442-445.
7. Rostom AY, el-Sayed ME. Fat necrosis of the breast: an unusual complication of lumpectomy and radiotherapy in breast cancer. Clin Radiol 1987;38:31.
8. Boyages J, Bilous M, Barraclough B, Langlands AO. Fat necrosis of the breast following lumpectomy and radiation therapy for early breast cancer. Radiother Oncol 1988;13:69-74.
9. Padhani AR, Yarnold JR, Regan J, Husband JE. MRI of induration in the irradiated breast. Radiother Oncol 2002;64:157.
10. Wenz F, Rempp K, Hess T, et al. Effect of radiation on blood volume in low-grade astrocytomas and normal brain tissue: quantification with dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol 1996;166:187-193.
11. de Vries A, Griebel J, Kremser C, et al. Monitoring of tumor micro-circulation during fractionated radiation therapy in patients with rectal carcinoma: preliminary results and implications for therapy. Radiology 2000;217:385-391.
12. Mayr NA, Yuh WT, Arnholt JC, et al. Pixel analysis of MR perfusion imaging in predicting radiation therapy outcome in cervical cancer. J Magn Reson Imaging 2000;12:1027-1033.
13. De La Paz RL, Ott IL, Paola T. Recurrent brain tumor versus radiation necrosis: comparison of MR relative cerebral blood volume maps and FDG-PET [Abstract]. Radiology 1995;197(P):169.
14. Dao TH, Rahmouni A, Campana F, Laurent M, Asselain B, Fourquet A. Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhanced MR imaging. Radiology 1993;187:751-755.
15. Heywang-Kobrunner SH, Schlegel A, Beck R, et al. Contrast-enhanced MRI of the breast after limited surgery and radiation therapy. J Comput Assist Tomogr 1993;17:891-900.
16. Blomqvist L, Fransson P, Hindmarsh T. The pelvis after surgery and radio- chemotherapy for rectal cancer studied with Gd-DTPA-enhanced fast dynamic MR imaging. Eur Radiol 1998;8:781-787.
17. Hawnaur JM, Zhu XP, Hutchinson CE. Quantitative dynamic contrast enhanced MRI of recurrent pelvic masses in patients treated for cancer. Br J Radiol 1998;71:1136-1142.
18. Yarnold JR, Owen JR, Ashton A, et al. Fractionation sensitivity of change in breast appearance after radiotherapy for early breast cancer: long-term results of a randomised trial [Abstract]. Radiother Oncol 2002;64(S25):77.
19. Parker GJ, Baustert I, Tanner SF, Leach MO. Improving image quality and T(1) measurements using saturation recovery turbo-FLASH with an approximate K-space normalisation filter. Magn Reson Imaging 2000;18:157-167.
20. Parker GJ, Suckling J, Tanner SF, Padhani AR, Husband JE, Leach MO. MRIW: Parametric analysis software for contrast-enhanced dynamic MR imaging in cancer. Radiographics 1998;18:497-506.
21. Donahue KM, Burstein D, Manning WJ, Gray ML. Studies of Gd- DTPA relaxivity and proton exchange rates in tissue. Magn Reson Med 1994;32:66-76.
22. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. I. Fundamental concepts. Magn Reson Med 1991;17:357-367.
23. Tofts PS, Berkowitz B, Schnall MD. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model. Magn Reson Med 1995;33:564-568.
24. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997;7:91-101.
25. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10:223-232.
26. Barcellos-Hoff MH. Radiation-induced transforming growth factor beta and subsequent extracellular matrix reorganization in murine mammary gland. Cancer Res 1993;53:3880-3886.
27. Barcellos-Hoff MH, Derynck R, Tsang ML, Weatherbee JA. Transforming growth factor-beta activation in irradiated murine mammary gland. J Clin Invest 1994;93:892-899.
28. Grotendorst GR, Paglia L, McIvor C, Barsky S, Martinet Y, Pencev D. Chemoattractants in fibrotic disorders. Ciba Found Symp 1985;114:150-163.
29. Remy J, Wegrowski J, Crechet F, Martin M, Daburon F. Long-term overproduction of collagen in radiation-induced fibrosis. Radiat Res 1991;125:14-19.
30. Martin M, Lefaix JL, Pinton P, Crechet F, Daburon F. Temporal modulation of TGF-beta 1 and beta-actin gene expression in pig skin and muscular fibrosis after ionizing radiation. Radiat Res 1993;134:63-70.
31. McAnulty RJ, Moores SR, Talbot RJ, Bishop JE, Mays PK, Laurent GJ. Long-term changes in mouse lung following inhalation of a fibrosis-inducing dose of 239PuO2: changes in collagen synthesis and degradation rates. Int J Radiat Biol 1991;59:229-238.
32. Delanian S, Balla-Mekias S, Lefaix JL. Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol. J Clin Oncol 1999;17:3283-3290.
33. Delanian S, Baillet F, Huart J, Lefaix JL, Maulard C, Housset M. Successful treatment of radiation-induced fibrosis using liposomal Cu/Zn superoxide dismutase: clinical trial. Radiother Oncol 1994;32:12-20.
34. Dion MW, Hussey DH, Doornbos JF, Vigliotti AP, Wen BC, Anderson B. Preliminary results of a pilot study of pentoxifylline in the treatment of late radiation soft tissue necrosis. Int J Radiat Oncol Biol Phys 1990;19:401-407.
35. Roberts TP. Physiologic measurements by contrast-enhanced MR imaging: expectations and limitations. J Magn Reson Imaging 1997;7:82-90.
36. Evelhoch JL. Key factors in the acquisition of contrast kinetic data for oncology. J Magn Reson Imaging 1999;10:254-259.
37. Weinmann HJ, Laniado M, and Mutzel W. Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR 1984;16:167-172.
38. Rijpkema M, Kaanders JH, Joosten FB, van der Kogel AJ, Heerschap A. Method for quantitative mapping of dynamic MRI contrast agent uptake in human tumors. J Magn Reson Imaging 200;114:457-463.
39. Li KL, Zhu XP, Waterton J, Jackson A. Improved 3D quantitative mapping of blood volume and endothelial permeability in brain tumors. J Magn Reson Imaging; 2000;12:347-357.
40. Buckley DL. Uncertainty in the analysis of tracer kinetics using dynamic contrast- enhanced T(1)-weighted MRI. Magn Reson Med 2002;47:601-606.
41. Padhani AR. Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging 2002;16:407-422.